A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease
Phase 4
Completed
- Conditions
- Alzheimer Disease
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 63
- Registration Number
- NCT00035204
The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 279
- Registration Number
- NCT00034749
A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX
Phase 3
Terminated
- Conditions
- Foot UlcerDiabetic FootSkin UlcerDiabetic Neuropathies
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 84
- Registration Number
- NCT00034788
Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
Phase 3
Completed
- Conditions
- DementiaAlzheimer DiseaseMental Disorders
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-02-01
- Target Recruit Count
- 473
- Registration Number
- NCT00034762
A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
Phase 3
Completed
- Conditions
- SchizophreniaPsychotic Disorders
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-01-10
- Target Recruit Count
- 141
- Registration Number
- NCT00034775